These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 19907151

  • 21. Non-HFE haemochromatosis.
    Wallace DF, Subramaniam VN.
    World J Gastroenterol; 2007 Sep 21; 13(35):4690-8. PubMed ID: 17729390
    [Abstract] [Full Text] [Related]

  • 22. [Hereditary and acquired iron overload].
    de Korwin JD.
    Nephrol Ther; 2006 Nov 21; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [Abstract] [Full Text] [Related]

  • 23. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R, Schranz M, Griffiths WJ, Baumgartner N, Hermann M, Lomas DJ, Pietrangelo A, Cox TM, Vogel W, Zoller H.
    Biochim Biophys Acta; 2014 Sep 21; 1842(9):1406-12. PubMed ID: 24859227
    [Abstract] [Full Text] [Related]

  • 24. Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.
    Radio FC, Majore S, Aurizi C, Sorge F, Biolcati G, Bernabini S, Giotti I, Torricelli F, Giannarelli D, De Bernardo C, Grammatico P.
    Blood Cells Mol Dis; 2015 Jun 21; 55(1):71-5. PubMed ID: 25976471
    [Abstract] [Full Text] [Related]

  • 25. Hemochromatosis: genetics and pathophysiology.
    Beutler E.
    Annu Rev Med; 2006 Jun 21; 57():331-47. PubMed ID: 16409153
    [Abstract] [Full Text] [Related]

  • 26. Hemochromatosis: genetic testing and clinical practice.
    Zoller H, Cox TM.
    Clin Gastroenterol Hepatol; 2005 Oct 21; 3(10):945-58. PubMed ID: 16234038
    [Abstract] [Full Text] [Related]

  • 27. Non-HFE hepatic iron overload.
    Pietrangelo A, Caleffi A, Corradini E.
    Semin Liver Dis; 2011 Aug 21; 31(3):302-18. PubMed ID: 21901660
    [Abstract] [Full Text] [Related]

  • 28. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ.
    Hum Mol Genet; 2003 Sep 01; 12(17):2241-7. PubMed ID: 12915468
    [Abstract] [Full Text] [Related]

  • 29. [Iron overload disease: recent findings].
    Licata A, Brucato V, Di Marco V, Barbaria F, Craxì A.
    Ann Ital Med Int; 2004 Sep 01; 19(3):145-54. PubMed ID: 15529941
    [Abstract] [Full Text] [Related]

  • 30. Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management.
    Nelson JE, Kowdley KV.
    Curr Gastroenterol Rep; 2005 Feb 01; 7(1):71-80. PubMed ID: 15701302
    [Abstract] [Full Text] [Related]

  • 31. [Iron overload and insulin resistance].
    Vantyghem MC, Girardot C, Boulogne A, Wemeau JL.
    Presse Med; 2005 Nov 05; 34(19 Pt 1):1391-8. PubMed ID: 16292193
    [Abstract] [Full Text] [Related]

  • 32. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, McLaren GD, Eckfeldt JH, McLaren CE, Reboussin DM, Gordeuk VR, Speechley MR, Reiss JA, Press RD, Dawkins FW, Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.
    Genet Test; 2007 Nov 05; 11(3):269-75. PubMed ID: 17949288
    [Abstract] [Full Text] [Related]

  • 33. Iron overload in the Asian community.
    Lok CY, Merryweather-Clarke AT, Viprakasit V, Chinthammitr Y, Srichairatanakool S, Limwongse C, Oleesky D, Robins AJ, Hudson J, Wai P, Premawardhena A, de Silva HJ, Dassanayake A, McKeown C, Jackson M, Gama R, Khan N, Newman W, Banait G, Chilton A, Wilson-Morkeh I, Weatherall DJ, Robson KJ.
    Blood; 2009 Jul 02; 114(1):20-5. PubMed ID: 19342478
    [Abstract] [Full Text] [Related]

  • 34. Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?
    Altès A, Bach V, Ruiz A, Esteve A, Remacha AF, Sardà MP, Felez J, Baiget M.
    Ann Hematol; 2009 Apr 02; 88(4):341-5. PubMed ID: 18820912
    [Abstract] [Full Text] [Related]

  • 35. Rare causes of hereditary iron overload.
    Ponka P.
    Semin Hematol; 2002 Oct 02; 39(4):249-62. PubMed ID: 12382200
    [Abstract] [Full Text] [Related]

  • 36. Molecular pathogenesis of hereditary hemochromatosis.
    Liu J, Pu C, Lang L, Qiao L, Abdullahi MA, Jiang C.
    Histol Histopathol; 2016 Aug 02; 31(8):833-40. PubMed ID: 27031690
    [Abstract] [Full Text] [Related]

  • 37. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene.
    Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A.
    J Clin Invest; 2001 Aug 02; 108(4):619-23. PubMed ID: 11518736
    [Abstract] [Full Text] [Related]

  • 38. EASL clinical practice guidelines for HFE hemochromatosis.
    European Association For The Study Of The Livereasl@easloffice.eu.
    J Hepatol; 2010 Jul 02; 53(1):3-22. PubMed ID: 20471131
    [Abstract] [Full Text] [Related]

  • 39. [Hypersiderosis and dissiderosis in the context of data on hemochromatosis microelementosis].
    Smirnov OA.
    Arkh Patol; 2008 Jul 02; 70(3):3-8. PubMed ID: 18727423
    [Abstract] [Full Text] [Related]

  • 40. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
    Sham RL, Phatak PD, West C, Lee P, Andrews C, Beutler E.
    Blood Cells Mol Dis; 2005 Jul 02; 34(2):157-61. PubMed ID: 15727899
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.